You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR TRETINOIN


✉ Email this page to a colleague

« Back to Dashboard


505(b)(2) Clinical Trials for TRETINOIN

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
OTC NCT01149876 ↗ Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots Completed Massachusetts General Hospital Phase 4 2010-06-01 The purpose of this study is to determine whether a topical Nu Skin product with or without a galvanic spa device improves brown spots on the face. The Nu Skin product will be compared to an over the counter moisturizer and tretinoin cream.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for TRETINOIN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002479 ↗ Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome Completed National Cancer Institute (NCI) Phase 2 1991-10-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of tretinoin in treating patients who have any stage mycosis fungoides or Sezary syndrome.
NCT00002479 ↗ Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome Completed Northwestern University Phase 2 1991-10-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of tretinoin in treating patients who have any stage mycosis fungoides or Sezary syndrome.
NCT00002658 ↗ Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia Unknown status Medical Research Council Phase 3 1994-01-01 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of different treatment regimens in treating patients who have acute myeloid leukemia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for TRETINOIN

Condition Name

Condition Name for TRETINOIN
Intervention Trials
Acne Vulgaris 25
Leukemia 15
Acne 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for TRETINOIN
Intervention Trials
Acne Vulgaris 28
Leukemia 24
Leukemia, Myeloid, Acute 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TRETINOIN

Trials by Country

Trials by Country for TRETINOIN
Location Trials
United States 275
Canada 16
Brazil 10
Australia 9
France 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for TRETINOIN
Location Trials
Pennsylvania 17
North Carolina 16
California 15
Florida 14
New York 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TRETINOIN

Clinical Trial Phase

Clinical Trial Phase for TRETINOIN
Clinical Trial Phase Trials
Phase 4 21
Phase 3 21
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for TRETINOIN
Clinical Trial Phase Trials
Completed 72
Unknown status 14
Recruiting 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TRETINOIN

Sponsor Name

Sponsor Name for TRETINOIN
Sponsor Trials
National Cancer Institute (NCI) 20
Bausch Health Americas, Inc. 9
Valeant Pharmaceuticals International, Inc. 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for TRETINOIN
Sponsor Trials
Other 121
Industry 64
NIH 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.